On Friday, Shares of Viacom, Inc. (NASDAQ:VIAB), added 0.50% and closed at $36.00 in the last trading session. The last trading range of the stock ranges between $35.65 and $36.27. The Special Committee of the Board of Directors of Viacom (NASDAQ: VIAB, VIA) recently declared that it has retained financial advisors in connection with the Special Committee’s evaluation of the request by National Amusements that Viacom explore a potential combination with CBS (CBS). The financial advisors are Morgan Stanley, Allen & Company and LionTree LLC.
The Special Committee, which is comprised of six independent Viacom board members, formerly engaged Debevoise & Plimpton LLP as its independent legal advisor.
Vereit Inc (NYSE:VER), dropped -0.83% and closed at $9.52 in the last trading session. The last trading range of the stock ranges between $9.51 and $11.09. The company’s Market capitalization is $9.14 Billion with the total outstanding Shares of 965.19 million. VEREIT, Inc. (VER) (“VEREIT” or the “Company”) declared that it anticipates to issue, jointly with its operating partnership, VEREIT Operating Partnership, L.P., its third quarter 2016 Quarterly Report on Form 10-Q on Wednesday, November 2, 2016.
The Company will also host an earnings conference call via audio webcast on that same day at 1 p.m. Eastern Time to discuss the financial results. The call will be conducted by Glenn J. Rufrano, VEREIT’s Chief Executive Officer, and Michael J. Bartolotta, VEREIT’s Chief Financial Officer.
Dow Chemical Co (NYSE:DOW), gained 0.89% and closed at $53.38 in the last trading session. The last trading range of the stock ranges between $53.02 and $53.76. The company’s Market capitalization is $60.68 Billion with the total outstanding Shares of 1.13 billion. During the 52-week trading session the minimum price at which share price traded, registered at $40.26 and reached to max level of $57.10. A new study finds substituting monounsaturated fats (MUFAs) for saturated fats in the diet could save the U.S. $25.7 billion in heart-disease related healthcare costs annually. The results, recently published by the Journal of Medical Economics, show both the public and private sectors would benefit, with Medicare saving $9.4 billion, private insurers saving $7.9 billion, and patients saving $2.2 billion through reduced out-of-pocket costs each year. The study also estimates as much as $1.2 billion in productivity could be saved annually from fewer lost work days.
The findings are based on a growing body of research demonstrating the benefits to heart health of replacing saturated fats with MUFAs, and come at a time when experts estimate healthcare costs will continue to increase faster than overall inflation and employee wages. Heart disease remains the No. 1 cause of death in the United States and data from the Centers for Disease Control and Prevention (CDC) show one-in-six healthcare dollars is spent on cardiovascular disease.
“To put our results in perspective, we found the reduction in heart disease that would result from Americans substituting MUFAs for saturated fats in their diet could lead to a healthcare cost savings that is four times the size of CDC’s annual budget,” said John Cawley, Ph.D., Cornell University, Department of Policy Analysis and Administration, and Department of Economics. “Moreover, reduced heart disease risk is associated with reduced job absenteeism, which benefits both employers and workers.”